{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:59:21Z","timestamp":1770487161891,"version":"3.49.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.toxlet.2018.06.1216","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T18:20:42Z","timestamp":1530814842000},"page":"288-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["In-silico approach for drug induced liver injury prediction: Recent advances"],"prefix":"10.1016","volume":"295","author":[{"given":"Neha","family":"Saini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2018.06.1216_bib0005","first-page":"325A","article-title":"HLA-A*33:01: 225 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds: 225","volume":"62","author":"Aithal","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.toxlet.2018.06.1216_bib0010","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hep.27206","article-title":"Human drug\u2010induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump","volume":"60","author":"Aleo","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.toxlet.2018.06.1216_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/gm350","article-title":"In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers","volume":"4","author":"Alfirevic","year":"2012","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bcp.13490","article-title":"Critical evaluation of causality assessment of herb\u2010drug interactions in patients","volume":"84","author":"Awortwe","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0025","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.carbpol.2013.07.018","article-title":"Antitumor and immunomodulatory activities of a polysaccharide from Artemisia argyi","volume":"98","author":"Bao","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0030","unstructured":"Biotranex LLC, 2017. Biotranex LLC granted patent for bile salt export protein BSEPcyteTM assay. https:\/\/www.prnewswire.com\/news-releases\/biotranex-llc-granted-patent-for-bile-salt-export-protein-bsepcyte-assay-300531098.html."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0035","series-title":"Primus Pharmaceuticals Withdraws Limbrel Capsules from the Market","author":"Botta","year":"2018"},{"issue":"36","key":"10.1016\/j.toxlet.2018.06.1216_bib0040","article-title":"Computational model of the fathead minnow hypothalamic\u2013pituitary\u2013gonadal axis: incorporating protein synthesis in improving predictability of responses to endocrine active chemicals","volume":"183","author":"Breen","year":"2016","journal-title":"Comp. Biochem. Physiol. Part C: Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.toxlet.2018.06.1216_bib0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0026-895X(24)05633-5","article-title":"2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin activation of the aryl hydrocarbon receptor\/aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through a CYP1A-independent mechanism in zebrafish","volume":"66","author":"Carney","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.toxlet.2018.06.1216_bib0050","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.toxlet.2018.06.1216_bib0055","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1021\/mp4001348","article-title":"Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia","volume":"10","author":"Chang","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0060","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfw142","article-title":"Computational modeling of plasma vitellogenin alterations in response to aromatase inhibition in fathead minnows","volume":"154","author":"Cheng","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0065","doi-asserted-by":"crossref","first-page":"41238","DOI":"10.1038\/srep41238","article-title":"Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity","volume":"7","author":"Choudhury","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0029-1240009","article-title":"Genetic association studies in drug-induced liver injury","volume":"29","author":"Daly","year":"2009","journal-title":"Semin. Liver Dis."},{"issue":"7","key":"10.1016\/j.toxlet.2018.06.1216_bib0075","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0080","doi-asserted-by":"crossref","first-page":"14662","DOI":"10.1371\/journal.pone.0014662","article-title":"Analysis of common and specific mechanisms of liver function affected by nitrotoluene compounds","volume":"6","author":"Deng","year":"2011","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.toxlet.2018.06.1216_bib0085","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2010.05.033","article-title":"Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury","volume":"53","author":"Donaldson","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0090","series-title":"Modelling Drug Induced Liver Toxicity: A Case Study for Pathway Analysis","author":"Elevier R & D Solutions","year":"2018"},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.1992.tb00562.x","article-title":"Drug\u2010induced hepatic injury: an analysis of 1100 cases reported to the Danish committee on adverse drug reactions between 1978 and 1987","volume":"232","author":"Friis","year":"1992","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.toxlet.2018.06.1216_bib0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11418-016-0972-6","article-title":"Anti-inflammatory and blood stasis activities of essential oil extracted from Artemisia argyi leaf in animals","volume":"70","author":"Ge","year":"2016","journal-title":"J. Nat. Med."},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0105","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/gast.2002.36061","article-title":"AGA technical review on the evaluation of liver chemistry tests","volume":"123","author":"Green","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0110","first-page":"13","article-title":"Study on Artemisia argyi essential oil: anti inflammatory, antianaphylatic and analgesic effects","volume":"2","author":"Han","year":"2005","journal-title":"J. New Med."},{"issue":"3-4","key":"10.1016\/j.toxlet.2018.06.1216_bib0115","first-page":"290","article-title":"Hepatotoxicity of antibiotics","volume":"58","author":"Hautekeete","year":"1995","journal-title":"Acta gastro-enterologicaBelgica"},{"issue":"5","key":"10.1016\/j.toxlet.2018.06.1216_bib0120","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","article-title":"HLA association of amoxicillin-clavulanate\u2013induced hepatitis","volume":"117","author":"Hautekeete","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0034-1375955","article-title":"Clinical features, diagnosis, and natural history of drug-induced liver injury","volume":"34","author":"Hayashi","year":"2014","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.tpj.6500442","article-title":"Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case\u2013control study","volume":"8","author":"Hirata","year":"2008","journal-title":"Pharmacogenomics J."},{"issue":"3","key":"10.1016\/j.toxlet.2018.06.1216_bib0135","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/ijms18030620","article-title":"A biomedical investigation of the hepatoprotective effect of radix salvia miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets","volume":"18","author":"Hong","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/molecules22040632","article-title":"A network-based pharmacology study of the herb-induced liver injury potential of traditional hepatoprotective Chinese herbal medicines","volume":"22","author":"Hong","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0145","doi-asserted-by":"crossref","first-page":"17311","DOI":"10.1038\/s41598-017-17701-7","article-title":"Development of decision Forest models for prediction of drug-induced liver injury in humans using a large set of FDA-approved drugs","volume":"7","author":"Hong","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.toxlet.2018.06.1216_bib0150","doi-asserted-by":"crossref","first-page":"14679","DOI":"10.3390\/ijms131114679","article-title":"Dual bioactivities of essential oil extracted from the leaves of Artemisia argyi as an anti melanogenic versus antioxidant agent and chemical composition analysis by GC\/MS","volume":"13","author":"Huang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0155","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1086\/381446","article-title":"Drug-induced liver injury","volume":"38","author":"Kaplowitz","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.toxlet.2018.06.1216_bib0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12859-017-1638-4","article-title":"Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints","volume":"18","author":"Kim","year":"2017","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.toxlet.2018.06.1216_bib0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","article-title":"Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis","volume":"8","author":"Kindmark","year":"2008","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0170","series-title":"Drug-Induced Liver Disease","article-title":"Histopathological evaluation of drug-induced liver disease","author":"Kleiner","year":"2013"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2017.06.003","article-title":"Predicting drug-induced liver injury: the importance of data curation","volume":"389","author":"Kotsampasakou","year":"2017","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0889-8553(21)00233-8","article-title":"Hepatotoxicity of anticholesterol, cardiovascular, and endocrine drugs and hormonal agents","volume":"24","author":"Lahoti","year":"1995","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2002-30105","article-title":"Epidemiology and individual susceptibility to adverse drug reactions affecting the liver","volume":"22","author":"Larrey","year":"2002","journal-title":"Semin. Liver Dis."},{"issue":"8","key":"10.1016\/j.toxlet.2018.06.1216_bib0190","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1210\/me.2010-0117","article-title":"Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity","volume":"24","author":"Lee","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0195","first-page":"51","article-title":"Research medicinal function of argy wormwood leaf and their development and utilization","volume":"16","author":"Li","year":"2002","journal-title":"Pri. J. Chin. Mater. Med."},{"issue":"9","key":"10.1016\/j.toxlet.2018.06.1216_bib0200","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1139\/f2011-066","article-title":"A computational model for asynchronous oocyte growth dynamics in a batch-spawning fish","volume":"68","author":"Li","year":"2011","journal-title":"Can. J. Fish. Aquat. Sci."},{"issue":"15","key":"10.1016\/j.toxlet.2018.06.1216_bib0205","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1039\/C7RA12957B","article-title":"The development and application of in silico models for drug induced liver injury","volume":"8","author":"Li","year":"2018","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.toxlet.2018.06.1216_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002310","article-title":"Translating clinical findings into knowledge in drug safety evaluation-drug induced liver injury prediction system (DILIps)","volume":"7","author":"Liu","year":"2011","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12906-017-1997-4","article-title":"Molecular network-based analysis of the mechanism of liver injury induced by volatile oils from Artemisiae argyi folium","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0220","first-page":"31","article-title":"Elucidating differences in the hepatotoxic potential of tolcapone and entacapone with dilisym\u00ae, a mechanistic model of drug\u2010induced liver injury","volume":"5","author":"Longo","year":"2016","journal-title":"CPT: Pharm. Syst. Pharm."},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0225","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3892\/etm.2016.3627","article-title":"Clinical characteristics of drug-induced liver injury and related risk factors","volume":"12","author":"Lu","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0230","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0235","doi-asserted-by":"crossref","first-page":"473","DOI":"10.14573\/altex.2013.4.473","article-title":"From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment","volume":"30","author":"MacKay","year":"2013","journal-title":"ALTEX"},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0240","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor \u03b3 modulate profibrogenic and proinflammatory actions in hepatic stellate cells","volume":"119","author":"Marra","year":"2000","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.toxlet.2018.06.1216_bib0245","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B","volume":"333","author":"McKenzie","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.toxlet.2018.06.1216_bib0250","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/etc.2972","article-title":"Linking mechanistic toxicology to population models in forecasting recovery from chemical stress: a case study from Jackfish Bay, Ontario, Canada","volume":"34","author":"Miller","year":"2015","journal-title":"Environ. Toxicol. Chem."},{"issue":"5","key":"10.1016\/j.toxlet.2018.06.1216_bib0255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/FPC.0000000000000209","article-title":"HLA-DRB1* 16: 01-DQB1* 05: 02 is a novel genetic risk factor for flupirtine-induced liver injury","volume":"26","author":"Nicoletti","year":"2016","journal-title":"Pharmacogenet. Genom."},{"issue":"11","key":"10.1016\/j.toxlet.2018.06.1216_bib0260","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e328355fe8f","article-title":"Abacavir induces loading of novel self-peptides into HLA-B* 57: 01: an autoimmune model for HLA-associated drug hypersensitivity","volume":"26","author":"Norcross","year":"2012","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.toxlet.2018.06.1216_bib0265","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gut.47.5.717","article-title":"Co-amoxiclav jaundice: clinical and histological features and HLA class II association","volume":"47","author":"O\u2019donohue","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0270","series-title":"Workshop Report on OECD Countries Activities Regarding Testing, Assessment and Management of Endocrine Disrupters","author":"OECD","year":"2010"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0275","series-title":"Guidance Document on Developing and Assessing Adverse Outcome Pathways","first-page":"45","author":"OECD","year":"2013"},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0280","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug\u2010induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fct.2014.06.013","article-title":"Structure\u2013toxicity relationship and structure\u2013activity relationship study of 2-phenylaminophenylacetic acid derived compounds","volume":"71","author":"Pang","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"10","key":"10.1016\/j.toxlet.2018.06.1216_bib0290","first-page":"769","article-title":"Hepatitis caused by clometacin (Dup\u00e9ran). Retrospective study of 30 cases. A model of autoimmune drug-induced hepatitis?","volume":"13","author":"Pariente","year":"1989","journal-title":"Gastroenterologieclinique et biologique"},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0295","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug\u2010induced cholestasis","volume":"44","author":"PauliMagnus","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0300","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fphar.2016.00442","article-title":"A New Structure-Activity Relationship (SAR) model for predicting drug-induced liver injury, based on statistical and expert-based structural alerts","volume":"7","author":"Pizzo","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.toxlet.2018.06.1216_bib0305","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0310","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acs.molpharmaceut.5b00659","article-title":"Disruption of BSEP function in HepaRG cells alters bile acid disposition and is a susceptive factor to drug-induced cholestatic injury","volume":"13","author":"Qiu","year":"2016","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.toxlet.2018.06.1216_bib0315","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/hep.21571","article-title":"Glucocorticoid signaling synchronizes the liver circadian transcriptome","volume":"45","author":"Reddy","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0320","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.25656","article-title":"Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: early discrimination between survival and death","volume":"56","author":"Remien","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0325","series-title":"Drug-Induced Liver Disease","first-page":"569","article-title":"Hepatotoxicity of immunosuppressive drugs","author":"Reuben","year":"2013"},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0330","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt\u2010homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0335","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug\u2010induced hepatic injuries: a French population\u2010based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.toxlet.2018.06.1216_bib0340","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cld.2007.06.003","article-title":"Causality assessment of drug-induced hepatotoxicity: promises and pitfalls","volume":"11","author":"Shapiro","year":"2007","journal-title":"Clin. Liver Dis."},{"issue":"7","key":"10.1016\/j.toxlet.2018.06.1216_bib0345","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1164\/rccm.2108091","article-title":"Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment","volume":"166","author":"Sharma","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.toxlet.2018.06.1216_bib0350","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.toxlet.2018.06.1216_bib0355","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2010.31.3197","article-title":"HLA-DQA1* 02: 01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer","volume":"29","author":"Spraggs","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"38","key":"10.1016\/j.toxlet.2018.06.1216_bib0360","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.3748\/wjg.v19.i38.6398","article-title":"New insights in bilirubin metabolism and their clinical implications","volume":"19","author":"Sticova","year":"2013","journal-title":"World. J. Gastroenterol"},{"issue":"9","key":"10.1016\/j.toxlet.2018.06.1216_bib0365","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","article-title":"A prospective nationwide study of drug-induced liver injury in Korea","volume":"107","author":"Suk","year":"2012","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.toxlet.2018.06.1216_bib0370","first-page":"33","article-title":"Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases","volume":"59","author":"Teschke","year":"2016","journal-title":"Deutsche Zeitschriftf\u00fcrAkupunktur"},{"issue":"2","key":"10.1016\/j.toxlet.2018.06.1216_bib0375","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00204-016-1723-x","article-title":"Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients","volume":"91","author":"Thiel","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0380","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jhep.2017.03.010","article-title":"Minocycline hepatotoxicity: clinical characterization and identification of HLA-B\u2217 35: 02 as a risk factor","volume":"67","author":"Urban","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0385","series-title":"Integrated Bioactivity and Exposure Ranking: A Computational Approach for the Prioritization and Screening of Chemicals in the Endocrine Disruptor Screening Program","author":"US EPA","year":"2014"},{"issue":"9","key":"10.1016\/j.toxlet.2018.06.1216_bib0390","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/14740338.2016.1194824","article-title":"Drug-induced hepatotoxicity in cancer patients-implication for treatment","volume":"15","author":"Vincenzi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0395","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","article-title":"The adverse outcome pathway concept: a pragmatic tool in toxicology","volume":"312","author":"Vinken","year":"2013","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.toxlet.2018.06.1216_bib0400","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/acs.chemrestox.5b00208","article-title":"Adverse outcome pathways and drug-induced liver injury testing","volume":"28","author":"Vinken","year":"2015","journal-title":"Chem. Res. Toxicol."},{"issue":"11","key":"10.1016\/j.toxlet.2018.06.1216_bib0405","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/17425255.2014.963555","article-title":"Pregnane X receptor and drug-induced liver injury","volume":"10","author":"Wang","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0410","doi-asserted-by":"crossref","first-page":"0146594","DOI":"10.1371\/journal.pone.0146594","article-title":"Predicting fecundity of fathead minnows (Pimephales promelas) exposed to endocrine-disrupting chemicals using a MATLAB\u00ae-based model of oocyte growth dynamics","volume":"11","author":"Watanabe","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0415","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fphar.2014.00240","article-title":"Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury","volume":"5","author":"Woodhead","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxlet.2018.06.1216_bib0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/toxsci\/kfw193","article-title":"Application of a mechanistic model to evaluate putative mechanisms of tolvaptan drug-induced liver injury and identify patient susceptibility factors","volume":"155","author":"Woodhead","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"56","key":"10.1016\/j.toxlet.2018.06.1216_bib0425","doi-asserted-by":"crossref","first-page":"95568","DOI":"10.18632\/oncotarget.21509","article-title":"Prediction on the risk population of idiosyncratic adverse reactions based on molecular docking with mutant proteins","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.toxlet.2018.06.1216_bib0430","volume":"135","author":"Zeng","year":"2017"},{"issue":"3-4","key":"10.1016\/j.toxlet.2018.06.1216_bib0435","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/minf.201500055","article-title":"In silico prediction of drug induced liver toxicity using substructure pattern recognition method","volume":"35","author":"Zhang","year":"2016","journal-title":"Mol. Inf."},{"issue":"6","key":"10.1016\/j.toxlet.2018.06.1216_bib0440","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/aps.2015.15","article-title":"Molecular network-based analysis of Guizhi-Shaoyao-Zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy","volume":"36","author":"Zhao","year":"2015","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418314644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418314644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T16:08:21Z","timestamp":1751731701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427418314644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":88,"alternative-id":["S0378427418314644"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.06.1216","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-silico approach for drug induced liver injury prediction: Recent advances","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.06.1216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}